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Background: Tissue integration and vessel formation are important criteria for the successful 
implantation of synthetic biomaterials for subcutaneous implantation.
Objective: We report the optimization of plasma surface modification (PSM) using argon (Ar), 
oxygen (O
2
) and nitrogen (N
2
) gases of a polyurethane polymer to enhance tissue integration 
and angiogenesis.
Methods: The scaffold’s bulk and surface characteristics were compared before and after 




. The viability and adhesion of human dermal fibroblasts (HDFs) 
on the modified scaffolds were compared. The formation of extracellular matrix by the HDFs 
on the modified scaffolds was evaluated. Scaffolds were subcutaneously implanted in a mouse 
model for 3 months to analyze tissue integration, angiogenesis and capsule formation.
Results: Surface analysis demonstrated that interfacial modification (chemistry, topography 
and wettability) achieved by PSM is unique and varies according to the gas used. O
2
 plasma 
led to extensive changes in interfacial properties, whereas Ar treatment caused moderate 
changes. N
2
 plasma caused the least effect on surface chemistry of the polymer. PSM-treated 
scaffolds significantly (P,0.05) enhanced HDF activity and growth over 21 days. Among all 
three gases, Ar modification showed the highest protein adsorption. Ar-modified scaffolds 
also showed a significant upregulation of adhesion-related proteins (vinculin, focal adhesion 
kinase, talin and paxillin; P,0.05) and extracellular matrix marker genes (collagen type I, 
fibronectin, laminin and elastin) and deposition of associated proteins by the HDFs. Subcu-
taneous implantation after 3 months demonstrated the highest tissue integration and angio-






Conclusion: PSM using Ar is a cost-effective and efficient method to improve the tissue 
integration and angiogenesis of subcutaneous implants.
Keywords: tissue integration, angiogenesis, surface modification, biomaterials, implants
Introduction
Subcutaneous synthetic implants are being used in several surgical settings surgery to 
restore anatomy following surgical resection including breast, facial, abdominal and 
pelvic reconstruction. However, unacceptable levels of infection and extrusion with 
subcutaneous synthetic materials cause significant patient morbidity and demands on 
health care resources. One main reason for the poor performance of synthetic materials 
is the poor integration and lack of angiogenesis with the surrounding subcutaneous 
tissue, which leads to a lack of anchorage and consequently infection and extrusion 
of the implant.1–3
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To improve the outcome of synthetic biomaterials, the 
substrate should aim to guide desired cell responses by 
mimicking the extracellular matrix (ECM). With the recent 
advancements in nanotechnology, nanocomposites offer 
substrates with a dimension that mimics the native ECM, 
improving their biocompatibility.4–8 Our group is currently 
developing a subcutaneous implant using a nanocomposite 
polyurethane.4,5 This polyurethane polymer has been exten-
sively tested and meets international standards (ISO 10993) 
for biocompatibility. Due to hydrophobic nature, it has 
been extensively investigated for hollow organs including a 
vascular graft9 and lacrimal duct,10 where flow of fluids is the 
primary requirement rather than tissue integration.
Several methods have been investigated to modify the 
tissue integration of synthetic materials, including the depo-
sition of proteins, growth factors and chemical groups.9–16 
Creating functional materials is critical to modify the biologi-
cal processes that occur at the material interface as they are 
controlled by the physiochemical properties at the material 
surface. Notably, manipulation of the surface chemistry and 
wettability of biomaterials is the simplest path for control-
ling surface interactions and improving biocompatibility.17,18 
Biomolecules including proteins and growth factors can sim-
ply be adsorbed onto the material surface or covalently linked 
via chemical reactions onto the surface.19 Many groups have 
illustrated that adsorption of ECM components onto material 
surfaces can direct cell behavior including fibronectin, lami-
nin, collagen and elastin.19 Several binding motifs from such 
ECMs have been identified and manufactured into short linear 
sequence of amino acids including RGD motifs to improve 
cell attachment to the biomaterial surface.19 However, with 
covalent bonding or adsorption techniques, understanding 
the correct presentation and gaining sufficient binding of 
the peptides or protein to direct cell behavior is difficult.20 
The delivery of growth factors to direct cell behavior has 
also been reported by trapping the biomolecules in the 
scaffolds during the manufacturing process.20 The release 
kinetics of the molecule can be controlled by the porosity 
of the scaffolds.20 However, often the growth factor loses 
its bioactivity due to the prolonged physical entrapment.20 
Electrostatic binding is an alternative advantageous technique 
as it mimics the natural interactions of the growth factors and 
the ECM.20 However, the presentation of biomolecules via 
this technique may not always be uniform and thus may not 
influence downstream pathways effectively.20 To overcome 
the challenges with using molecules to create a biometric 
surface, a biomaterial’s surface chemistry can be altered 
to direct cell behavior.21 Several chemical groups have 
been shown to influence cell behavior including carboxyl 
(-COOH), amine (-NH
2
), methyl (-CH3) and hydroxyl 
(-OH) groups.21 Studies have shown -NH
2
 improves adhe-
sion, growth and matrix formation.22,23 Carboxyl groups 
have been shown to improve the adsorption of proteins and 
allow for cell adhesion.24 Several techniques can introduce 
such chemical groups onto the material surface including 
ion beam implantation and ion beam exchange.25 However, 
these techniques require extensive training and high costs.26 
To overcome these challenges, an alternative method of 
modifying the surface chemistry of implants is using plasma 
surface modification (PSM).
PSM is an economical and effective method to control the 
physiochemical properties of biomaterials surfaces.18 PSM 
can modify the surface’s wettability by altering the surface 
chemistry and topography. Such physiochemical changes 
have been shown to enhance cell adhesion and prolifera-
tion, guide cell responses and modify the blood–biomaterial 
interface with the result of improving materials applicabil-
ity for clinical use.27–39 An important advantage of PSM is 
that the treatment can be used to tune the surface chemical 
composition and wettability without changing the material’s 
bulk properties.
Radiofrequency plasma is the most widely used source 
of plasma, which involves passing an electric current 
through a gas.18 Various gases have been used with PSM to 
impart specific surface chemistries or etching effects to alter 
surface topography in order to tune the surface composition. 
Despite the extensive exploration of PSM over the years for 
modifying the interfacial properties of materials, there are 
no comprehensive studies documenting the effect of various 
gaseous plasmas on the characteristics of the biomaterial 
surface, or extensive in vitro and in vivo evaluation to confirm 
their efficacy. The majority of studies reported have used a 
variety of gases, parameters and materials, so it is difficult to 
compare the efficiency of various PSM methods.18
This study aimed to compare three commonly used gases 
for PSM, including argon (Ar), oxygen (O
2
) and nitrogen 
(N
2
), to optimize the plasma process to enhance tissue 
integration and angiogenesis of polyurethane scaffolds. 
In this study, we optimized the PSM process by treating 
scaffolds for various length of time, to determine the effect 
on polyurethane’s surface and bulk properties. The study 
was then expanded by in vitro and in vivo studies to find 
the most efficient modification process to enhance tissue 
integration and angiogenesis. The method developed in this 
study can be easily translated to other biomaterial surfaces, 
offering a significant advancement in developing materials 
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The polymer was synthesized using a 2-part method as 
described previously.11,12 In brief, polycarbonate polyol 
(2000 molecular weight [Mw]) and trans-cyclohexanechlo-
roydrinisobutyl-silses-106 quioxane (Hybrid Plastics Inc., 
Hattiesburg, MI, USA) were mixed followed by Polydehral 
Oligomeric Silsesquioxane (POSS) cages being dissolved into 
the polyol solution at 70°C. Then, 4, 4′-methylenebis(phenyl 
isocyanate) was added to form a pre-polymer. Following this, 
dimethylacetamide (DMAC) was then added slowly with 
chain extension performed by cooling the solution to 40°C. 
This led to the synthesis of the POSS-modified polycarbonate 
urea-urethane (PU) in DMAC solution. The scaffolds were 
manufactured using a salt-leaching method as described 
previously.11,12 A 3:7 wt ratio of sodium chloride (NaCl) to 
PU was used in all experiments. The NaCl/PU mixture was 
first poured onto steel molds and then placed in an oven 
at 65°C for 4–5 hours until all the solvent had evaporated. 
Casted polymer was then placed into deionized water for 7 
days to remove all NaCl to produce porous scaffolds. For 
cell culture analysis, scaffolds were cut into circular discs 
of 16 mm diameter for use in 24-well plates.
Plasma surface modification (PSM)
PSM was performed using a radio frequency plasma genera-
tor configured to 40 kHz at 100 W and a flow rate of 0.4 mbar. 





 gas, for 1, 2.5, 5, 7.5 or 10 minutes. Untreated (Con) 
scaffolds were used as the control.
contact angle measurements
The static water contact angle was analyzed using the ses-
sile drop method using the DSA 100 instrument (KRUSS, 
Hamburg, Germany) as described previously (n=6).11,12 The 
static contact angle was measured on six scaffolds after varying 
the length of time of plasma exposure from 1 to 10 minutes.
Mechanical testing
The mechanical properties of scaffolds after PSM were 
analyzed with a Instron-5565 tensile 224 tester as described 
previously.11,12 The Average Young’s modulus of elasticity 
was reported following analysis of six independent scaf-
folds (n=6).
scanning electron microscopy (seM)
The scaffold’s surface structure and architecture, specifi-
cally the pore size and porosity (n=3), were analyzed using 
SEM.11,12 In brief, the scaffolds were fixed with 2.5% w/v 
glutaraldehyde/PBS for 48 hours. Following this, the scaf-
folds were critically point dried using CO
2
. The scaffolds 
were then gold-coated using a sc500 (EMScope; Quorum 
Technologies, Lewes, UK) sputter coater before imaging 
using a FEI Quanta 200F Scanning Electron Microscope.
X-ray photoelectron spectroscopy 
(XPs) studies
The treated and untreated scaffold’s surface chemistry was 
evaluated using a Thermo Scientific K-Alpha spectrometer, 
as described previously (n=3).11,12 In brief, monochromatic Al 
Kα X-rays (h=1,486 eV) were focused to a 400-µm diameter 
spot on the scaffold surface, defining the analysis area. The 
analysis depth was at the photon energies 5–10 nm. Survey 
spectra demonstrated the elemental composition of the 
surface. High-resolution spectra of the principle core line of 
each element present were then acquired for chemical state 
identification. Then, high-resolution spectra were fitted with 
Gaussian–Lorentzian peaks using the CasaXPS software to 
deconvolute different chemical environments. Gaussian–
Lorentzian peaks were fitted using CasaXPS software to 
deconvolute different chemical environments.
atomic force microscopy (aFM)
The roughness of the scaffolds surface was evaluated using an 
AFM (TAP150A) in the tapping mode (spring constant 2.919 
n/m) as described previously (n=3).11,12 In brief, the root mean 
square roughness was calculated from the 5 µm scan of three 
areas using the NanoScope® analysis software version 1.40 
(Bruker Corporation, Billerica, MA, USA). The PeakForce 
quantitative nanomechanical mapping was used to obtain an 
FV modulus using the modified Hertzian model.
gel permeation chromatography (gPc)
Molecular weight averages and polymer dispersity were deter-
mined by GPC analysis. Scaffolds were prepared to 1 mg/mL 
concentration and passed through a 0.22 µm nylon filter 
before measurement. GPC measurements were performed 
on an Agilent 1260 infinity system equipped with 2 PLgel 5 
µm mixed-D columns (300×7.5 mm), a PLgel 5 mm guard 
column (50×7.5 mm), a differential refractive index (DRI) 
and variable wavelength detector. The temperature of the col-
umns and DRI was maintained at 50°C. The system was eluted 
with DMF containing 5 mM ammonium tetrafluoroborate 





at a flow rate of 1 mL/min and the DRI detector was 
calibrated with linear narrow poly(methyl methacrylate) 
standards with narrow molecular weight distribution (n=3).
Differential scanning calorimetry (Dsc)
The polymer’s glass transition temperature (T
g
) was mea-
sured post-PSM at 5 and 10 minutes of treatment using a 
Q2000 DSC (TA Instruments Ltd., Elstree, UK). Scaffolds 
(5–10 mg) were weighed in hermetic Tzero aluminum pans. 
An empty pan, matched to the weight of the scaffold pan, 
was used as a reference. The scaffolds were heated from 
0°C to 250°C at 20°C/min. Data were analyzed with Uni-
versal Analysis 2000 with N
2
 used as the purge gas. DSC 
thermograms were drawn with Origin Pro 9.1 software (n=3; 
OrginLab, Northampton, MA, USA).
Protein adsorption studies
Total protein adsorption study
Total serum protein adsorption on unmodified and modified 
scaffolds was determined using bicinchoninic acid assay, 
as described previously (n=6).11,12
Functional presentation of cell-binding domains of 
adsorbed fibronectin and vitronectin
The accessibility of cell-binding domains of bFN and bVN 
adsorbed on the scaffolds was examined by ELISA using 
monoclonal antibodies (mAbs) directed to epitopes of the 
RGD-containing domains as described by Barrias et al.16 
In brief, the scaffolds were incubated in the protein solu-
tions (bFN or bVN) of different concentrations at 37°C. 
After washing with PBS, all surfaces were blocked with 1% 
w/v BSA/PBS and then incubated with specific mouse anti-
bovine mAbs at predetermined optimal concentrations (0.17 
µg/mL antibFN and 1 µg/mL anti-bVN in 1% w/v BSA/PBS, 
Alpha Laboratories, Eastleigh, UK) for 1 hour at 37°C. After 
washing three times in PBS, scaffolds were incubated with 
horseradish peroxidase-conjugated anti-mouse IgG (H+L) 
secondary antibody (1:1,000 in 1% w/v BSA/PBS; Fisher 
Scientific, Loughborough, UK) for 1 hour at 37°C. After 
further washing, scaffolds were incubated in o-phenylene-
diamine dihydrochloride substrate (0.4 mg/mL in 0.05 M 
phosphate–citrate buffer, pH 5.0, with 0.012% v/v hydrogen 
peroxide). The OD of the supernatant was then read using a 
spectrophotometer at 450 nm with reference to 620 nm.
Integrin-blocking experiments
The role of specific integrin involved in the fibroblast adhe-
sion to the plasma-modified scaffolds was investigated as 
described by Kalaskar et al.17 Human dermal fibroblasts 
(HDFs) cells were trypsinized, counted and incubated for 
30 minutes in the presence or absence of integrin-blocking 
antibodies α5β1 and α5β3 (Abcam, Cambridge, UK) from 
1 to 10 mg/mL in cell culture medium at 37°C. The cells 
(treated with and without blocking antibodies) were seeded 
at a density of 50,000 cells/cm3 on the scaffolds treated with 
different PSMs. The number of attached cells was counted 
after 3 hours and cell adhesion was calculated by counting 
the number of attached cells in three different random fields 
of view in triplicate cultures.
In vitro biocompatibility testing
cell culture and cell seeding
HDFs obtained from the European Collection of Authenticated 
Cell Culture (ECACC) were maintained in Dulbecco’s Modified 
Eagle’s Medium with 10% fetal bovine serum and 1% antibiotic 
solutions (Sigma-Aldrich, St Louis, MO, USA) as described 
previously.11,12 For in vitro experiments, 16 mm scaffolds 
were placed into the 24-well plates, for 24 hours in complete 
medium before cell seeding. Each scaffold was seeded with 
1×104 cells/cm2. Every three days, the medium was changed.
cellular adhesion and morphology
To study HDF architecture seeded on the scaffolds, the 
cytoskeleton was stained with actin-phalloidin after 
24 hours.11,12 HDF viability was evaluated using Alamar 
Blue™ assay (Sigma-Aldrich) and the Fluorescence Hoechst 
DNA Quantification Kit (Sigma-Aldrich) examined DNA 
content on days 1, 2, 4, 7, 14 and 21 as described previously 
(n=6).11,12
gene expression by rT-qPcr
Real-time quantitative polymerase chain reaction (RT-
qPCR) was performed as described previously.40 First, 
RNA was extracted using Tri-Reagent (Life Technologies, 
Waltham, MA, USA) at 7 and 14 days. Second, Moloney 
murine leukemia virus reverse transcriptase was used to 
retro-transcribe the RNA (Promega, Madison, WI, USA). 
Following this, RT-qPCR was completed using the ABI Prism 
7500 sequence detection system (Thermo Fisher Scientific, 
Waltham, MA, USA) with QuantiTect SYBR Green PCR kit 
(Qiagen, Hilden, Germany). GAPDH was used as the house-
keeping gene to normalize the data using the 2-ΔΔCt method. 
The primers used in the study are listed in Table 1.
Immunocytochemistry
The expression of ECM and adhesion-related proteins 
was using a method as previously described.40 At 14 days, 
the medium was removed and the scaffolds were washed 
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and fixed in 4% paraformaldehyde. Following overnight 
incubation, the scaffolds were further washed. Following 
permeablization (0.5% Triton X-100), the scaffolds were 
blocked (0.5% BSA). Following incubation with primary 
antibodies overnight at 4°C, further washing was done 
before the scaffolds were incubated in secondary antibody 
for 2 hours (488 Alexa secondary antibody, 1:500). Finally, 
the cell nuclei were stained with Hoechst 33258 (2.5 µg/
mL final concentration). Antibodies used in this study for 
immunocytochemistry are shown in Table 2.
enzyme-linked immunosorbent assay (elIsa) of 
vascular endothelial growth factor (VegF)
The VEGF secretion by the HDFs was assessed using ELISA 
analysis (Quantikine; R&D Systems, Inc., Minneapolis, MN, 
USA) according to manufacturer instructions. On days 4, 7, 
10 and 14, the cell culture supernatant was taken and evalu-
ated using ELISA as described previously.41
In vivo analysis
Following PSM treatment, two 4 mm (diameter) by 1 mm 
(thickness) discs were subcutaneously implanted in the 
dorsum of one 4-month-old BALB/c mice (Charles River 
Laboratories, Wilmington, MA, USA) as described previ-
ously (n=6).11 The disc was implanted via a small incision and 
closed with interrupted 5,0 monocryl. All experiments were 
approved by the local governmental animal care committee 
and performed according to animal welfare UK legislation. 
At 6 and 12 weeks, using CO
2
 asphyxiation, the animals were 
sacrificed and the scaffolds excised and fixed in 4% paraform-
aldehyde. The scaffolds were excised with approximately 
0.5 cm surrounding circular dermis. Fixed scaffolds were then 
paraffin embedded and cut into 3 µm sections for histological 
analysis. H&E staining was conducted according to standard 
procedures to assess tissue integration and CD31 immuno-
histochemistry staining for endothelial cells detection as per 
a previous study.11 The study was approved and conducted 
according to the animal research UK Home Office Guidelines.
statistical analysis
GraphPad (Prism) was used to conduct statistical analysis 
using one- or two-way ANOVA with Tukey HSD post 
Table 1 The rT-qPcr primer sequences used in this study




collagen type I F aTgccTggTgaacgTggT
r aggagagccaTcagcaccT
56 26









































Abbreviation: rT-Pcr, real-time polymerase chain reaction.
Table 2 Primary antibody details used in this study
Antibody Host Manufacturer Dilution Incubation
Vinculin Mouse abcam (ab18058) 1:200 Overnight
4°c
elastin rabbit abcam (ab21607) 1:200 Overnight
4°c
collagen type I rabbit abcam (ab34710) 1:200 Overnight
4°c
Fibronectin rabbit abcam (ab2413) 1:200 Overnight
4°c









Untreated scaffolds (Con) demonstrated a static water 
contact angle of 67°±7°. The contact angle of the scaffolds 
significantly (P,0.05) decreased after 1 minute of Ar 
(32.2°±2°), N
2
 (62.7°±4°) and O
2
 (14.8°±7°) treatment com-
pared with unmodified scaffolds (Con; Figure 1A).
roughness using aFM





 treatment. Unmodified scaffolds 
(Con) had a roughness of 8±1 nm (Figure 1B). Changes in 
surface roughness following Ar and N
2
 were only significant 
Figure 1 The effect of ar, N2 and O2 plasma treatments on the (A) wettability (static water contact angle), (B) surface roughness and (C) surface elastic modulus of 
polyurethane scaffolds.
Notes: changes in surface properties are presented as a function of treatment time. Normalized elemental composition measured by XPs analysis for various duration 
plasma treatment times is presented as (D) ratio of carbon content, (E) ratio of nitrogen content and (F) ratio of oxygen content.
Abbreviations: ar, argon; con, untreated; N2, nitrogen; O2, oxygen; XPs, X-ray photoelectron spectroscopy.
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compared with control after 5 minutes of treatment time 
(N
2
, 1 minute, 9±1 nm; N
2
, 5 minutes, 13±2 nm; Ar, 1 minute, 
9±1 nm; Ar, 5 minutes, 11±2 nm). However, O
2
 plasma led 
to linear increase in surface roughness with treatment time 
(O
2
, 1 minute, 16±3 nm; O
2
, 10 minutes, 38±4 nm), suggest-
ing it was the most aggressive plasma treatment, and such 
changes were confirmed using SEM (Figure S1).
surface elastic modulus using aFM
Ar and N
2
 plasma treatment showed no change in the surface 
elastic modulus as the treatment time increased compared 
with control (Con; Figure 1C). However, with O
2
 treatment, 
the surface elastic modulus increased linearly as the treatment 
time increased (P,0.05).
XPs measurements
For XPS analysis, the relative molar concentrations of C, N 
and O from all scaffolds were normalized and presented as 
shown in Figure 1D–F. The C/(N+O) ratio showed a stepwise 
decrease after treatment with Ar and O
2
. It is suggested that 
this trend may be related to the removal of residual carbon 
contamination from the surface (Figure 1D). Conversely, the 
C/(N+O) ratio did not follow any definite pattern after the 
N
2
 treatment. The observed trend suggests there is a cyclic 
removal and deposition of carbon from the surface of the 
material under such conditions.
On the other hand, the N/(C+O) ratio only showed small 
changes after treatment with all three gases (Figure 1E), 
suggesting no significant changes to surface N concentra-
tion for all the scaffolds. For the O/(C+N) ratio, a significant 
increase was observed during the O
2
 treatment after one 
minute (Figure 1F). Further scaffold treatment did not bring 
an increase of the O/(C+N) ratio. For the Ar treatment, the 
O/(C+N) ratio increased gradually until five minutes, which 
remained constant even after longer treatment times. N
2
 treat-
ment did not follow any particular trend. The calculated ratio 
suggests a similar pattern as that observed for the C/(N+O) 
treated with N
2
 plasma. Overall, the C ratio decreases with Ar 
and O
2





 treatment, on other hand, does not 
seem to have a significant effect over the polymer chemistry 
during the treatment process.
Bulk properties including mechanical 
testing, Dsc analysis and molecular 
weight analysis
The changes in bulk properties of the scaffolds after PSM 
were examined by the GPC, DSC and mechanical properties. 
After 5 minutes of treatment, irrespective of the type of gas, 
there were no significant changes found in average molecular 
number (M
n
) or average molecular weight (Mw) using GPC 
(Figure S2). After modification with plasma treatment, there 
was no difference in the Young’s modulus of the scaffolds 




 compared with untreated scaffolds 
(Con; Figure S3). There were no significant changes in 
the T
g
 after different PSM techniques using DSC analysis 
(Figure S4).
hDF adhesion
For all the gaseous plasma, 5 minutes provided the highest 
cellular attachment (Figure 2A). However, among all the test 
gases for 5 minutes, the highest cell adhesion at 24 hours was 






When cell morphology was examined by staining 
cytoskeleton of the cells, HDF cells demonstrated spreading 
on all plasma-modified scaffolds and unmodified scaffolds 
(Figure 2B). In addition to this, HDF vinculin expression was 
confirmed on all scaffolds by immunocytochemistry after 
24 hours. The expression of vinculin, focal adhesion kinase 
(FAK), talin and paxillin was higher on the PSM scaffolds 
compared with unmodified scaffolds (P,0.05). Among the 
gases tested, the expression of adhesion-related genes was 





 scaffolds (Figure 2C).
hDF viability and growth
Short-term cellular viability, determined using Alamar Blue 
assay and DNA content analysis, was significantly higher 
on plasma-modified scaffolds compared with unmodified 
control scaffolds with all treatment gases (P,0.05; Figure 3). 
For all treatment gases, the greatest level of cell growth was 
observed after 5 minutes of treatment compared with other 
treatment times.
Total protein adsorption
The type, amount and conformation of the essential pro-
teins at surface interface determine the cell adhesion, their 
attachment and long-term growth. In order to understand 
the increase in growth of HDF cells on the PSM scaf-
folds, total protein adsorption was quantified on all scaf-
folds (Figure 4A). PSM scaffolds showed significantly 
higher amount of total protein adsorption compared with 
unmodified scaffolds. Among various treatment times used, 
5 minutes of treatment with all test gases plasma led to the 
highest protein adsorption from serum containing media 
compared with control. Furthermore, when various test 
gases are compared, Ar (5 minutes) showed the highest 









. To analyze 
the role of specific proteins in cell adhesion, the most com-
mon ECM proteins, FN and VN, adsorption was quantified 





-treated scaffolds along with tissue culture plate 
(TCP; Figure S5), which reached saturation after 5 µg/mL, 
whereas, VN adsorption was found to be the highest on Ar 
along with TCP (Figure S5). Blocking integrin receptors for 
VN and FN demonstrated that the fibroblasts adhered to the 
modified surfaces using different receptors (Figure 4B and 














 on Ar-modified surfaces. Since 5 minutes of treatment 
showed the highest protein adsorption, followed by cell 
viability and growth with all the gases, this treatment time 
was further used to understand the mechanism of cellular 
interaction in terms of role of specific protein adsorption, 
interaction of cell surface receptors and their effect on 
tissue integration and angiogenesis.
ecM formation in vitro
The mRNA expression and release of ECM factors of col-
lagen type I, elastin, laminin and fibronectin were greater on 





(P,0.05; Figure 5). There was no difference in collagen 
type III expression by the HDFs between the scaffolds 
(Figure 5). The protein expression of collagen, elastin and 
fibronectin by the HDFs was confirmed on the scaffolds using 
immunocytochemistry after PSM with all gases, as well as 
on unmodified scaffolds (Figure S6).
assessment of tissue integration and 
angiogenesis in vivo
To assess the ability of the scaffolds to support tissue inte-
gration in vivo, the scaffolds were subcutaneously implanted 
for 6 and 12 weeks in a mice model and levels of tissue 
integration and angiogenesis were compared. Figure 6A 
shows the histology and immunohistochemistry of the 
explanted scaffolds treated with the three different gases 
Figure 2 Attachment of the HDF on the scaffolds treated with plasma surface modification after 24 hours.
Notes: (A) DNa assay for various treatment times using ar, N2 and O2 plasma treatment shows the highest level of cell attachment post 5 minutes of PsM treatment. 
(B) The effect of plasma modification on actin cytoskeleton organization and vinculin expression shows cell spreading on all scaffolds, with evidence of FAKs being formed 
after 24 hours (white arrows) (green: vinculin staining; red: actin filaments and blue: nucleus staining using DAPI). (C) Quantification of gene expression of adhesion-related 
genes, vinculin, FAK, talin and paxillin shows significant upregulation (*P,0.05), on Ar-modified scaffolds compared with other plasma gases and untreated scaffolds, after 
5 minutes of treatment. Fold change represents the differences compared with housekeeping gene GAPDH of cells grown on unmodified scaffolds (Con).
Abbreviations: Ar, argon; Con, untreated; FAK, focal adhesion kinase; HDF, human dermal fibroblast; N2, nitrogen; O2, oxygen; TcP, tissue culture plate; Neg con, negative 
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and unmodified scaffolds. Quantification of H&E staining 
confirms significantly higher level of tissue ingrowth in the 





unmodified scaffolds at 6 and 12 weeks (P,0.05; Figure 6B). 
The degree of capsule formation was also measured after 
12 weeks and found to be significantly reduced after PSM 
compared with unmodified scaffolds (Figure S7). Vascular-
ization in vivo was assessed using CD31 staining to identify 
capillaries growing into the scaffolds after different PSM 
(Figure 7A). Analysis indicated that Ar-modified scaffolds 
had greater vessel formation than other plasma-modified 
scaffolds and unmodified scaffolds (P,0.05; Figure 7B). 
Furthermore, in vitro quantification of the secretion and 
expression of angiogenic growth factors, vascular endothelial 
growth factor (VEGF) and basic fibroblast growth factor, was 





-modified scaffolds (Figure 7C).
Discussion
Surgical implants fail due to poor integration and lack of 
vascularization with the surrounding tissue.2 In this study, 
we used a cytocompatible material polyurethane to overcome 
that challenge by modifying it with PSM. Even though the 
usefulness of PSM has been widely documented, there is a 
lack of information on the efficiency of various gases used 
in PSM and optimal process parameters, which can be used 
to enhance tissue integration and angiogenesis of synthetic 
implants.
From the surface and bulk analyses, it is clear that poly-
mer bulk properties remain unaffected by plasma treatment 
for various length of time and only the surface interfacial 
properties were altered. This is in agreement with previous 
reports, which suggest, that PSM has no effect on the bulk 
properties of materials.11,42,43 Detailed surface analysis 
revealed that all treatment gases significantly decreased the 
surface wettability, and led to an increase in topography and 
surface elastic modulus of the PSM scaffolds compared with 
unmodified scaffolds (Figure 1; P,0.05). The O
2
-treated 
scaffolds demonstrated an increasing roughness and surface 
elastic modulus as treatment time increased. However, on 
the other hand, N
2
 and Ar treatment showed very small 
changes to the roughness and the surface elastic modulus 
over 10 minutes. The surface wettability of the scaffolds was 
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Figure 3 Human dermal fibroblast viability (A) and DNa (B) over 21 days on the scaffolds treated with plasma surface modification.
Note: Viability was measured using alamar Blue and DNa assay, respectively, for ar, N2 and O2 plasma for various treatment times (n=6) compared with untreated 
scaffolds (con).
Abbreviations: ar, argon; con, untreated; N2, nitrogen; O2, oxygen.







 surface modification also showed a greater effect on 
decreasing the contact angle of the scaffolds after similar 
exposure rates of Ar and N
2
 PSM.
The decrease in the contact angle and the increase in 
the surface roughness following O
2
 plasma are consistent 
with previous reports.27 Pappa et al found that O
2
 plasma 
significantly decreased the contact angle and increased the 
surface roughness of polycaprolactone polymer surfaces 
due to the introduction of polar groups on the surface of the 
polymer.27 Shah et al also demonstrated similar decreases 
in contact angle findings following the Ar and N
2
 treatment 
of polylactic acid surfaces.30 N
2
 has been shown to cause 
hydrophilic surfaces due to the deposition of -NH
2
 chemical 
functional groups.36 Ar has been shown to create hydrophilic 
surfaces due to deposition of polar functional groups (-OH) 
groups.33 In this study, we found a small increase in rough-
ness after 5 minutes of Ar and N
2
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Figure 4 Protein adsorption studies. (A) Total protein adsorption on the scaffolds after plasma surface modification. Total serum protein adsorption was evaluated using 
the BCA assay. Total serum protein adsorption on all scaffolds was significantly higher after 5 minutes of PSM for all the test gases (****P,0.0001). ar shows the highest 
protein adsorption among all the scaffolds (n=6). (B) Fibronectin and (C) vitronectin integrin-blocking experiments to assess specificity of adsorbed proteins on the scaffolds 
treated with plasma surface modification.
Notes: Blocking of the fibronectin receptor α5β1 using fibronectin-blocking antibody (Anti-FN) led to dose-dependent decreased cell adhesion on the N2- and O2-treated 
scaffolds but not on Ar-treated scaffolds, confirming the role of fibronectin-mediated attachment on N2- and O2-treated scaffolds. Blocking of the vitronectin receptor αVβ3 
using vitronectin-blocking antibody (anti-VN) led to dose-dependent decreased cell adhesion on the ar-treated scaffold but not on N2- and O2-treated scaffolds, confirming 
the dominant role of vitronectin-mediated attachment on ar scaffolds (n=6).
Abbreviations: ar, argon; Bca, bicinchoninic acid; con, untreated; N2, nitrogen; O2, oxygen; PSM, plasma surface modification; TCP, tissue culture plate.























Figure 5 Gene expression of ECM markers by the human dermal fibroblasts on 
plasma-modified scaffolds using RT-qPCR.
Notes: Gene expression confirmed the upregulation of ECM markers significantly 
on the Ar-modified scaffolds after 14 days compared with other scaffolds (*P,0.05). 
All scaffolds were treated with 5 minutes of respective plasma surface modification. 
Fold change represents the differences compared with housekeeping gene gaPDh 
of cells grown on unmodified scaffolds (Con). *P,0.05.
Abbreviations: ar, argon; col I, collagen type I; col III, collagen type III; 
Con, untreated; ECM, extracellular matrix; FN, fibronectin; Lm, laminin; N2, nitrogen; 
O2, oxygen; rT-qPcr, real-time quantitative polymerase chain reaction.
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studies have shown both an increase and decrease in surface 
roughness following Ar and N
2
 plasma treatment.30,32,37,39 The 
differences in the literature may be due to varying intensities 
of the plasma gases generated due to contrasting method-
ology within studies.30
The XPS analysis confirmed that Ar and O
2
 plasma treat-
ment acted as an effective carbon remover. A decrease in the 
carbon ratio and increase in the N
2
 ratio seemed proportional 
with these two treatment gases. As carbon was removed, 
underlying N
2
 from scaffolds surface was possibly exposed. 
It should also be noted that part of detected carbon could be 
associated to adventitious contamination, which is commonly 
observed in XPS analysis. Ar and O
2
 plasma treatments also 
showed an increase in O
2
 deposition. On the other hand, 
N
2
 treatment showed a pattern that could be demonstrating 
cyclical N
2
 deposition, carbon removal and O
2
 deposition 
from the surface, suggesting that there was very little effect 
on surface chemistry. Furthermore, this also shows that N
2
 
plasma caused the smallest change to the scaffold’s surface 
chemistry. Taking all surface analysis results into consider-
ation, it is safe to suggest that among all three gases tested, 
O
2
 treatment brought the most significant changes, Ar showed 
moderate changes and N
2
 treatment had the least effect on 
the surface properties. These changes may be accounted for 
by the difference in the reactivity of the plasma gas.30 The 
treatment of reactive gases like O
2
 brings about more surface 
changes than less reactive gases such as Ar and N
2
.30
The changes in bulk properties post-PSM were investi-
gated in terms of mechanical properties, Mw and Mn, and 
T
g




 treatment. The 
tensile mechanical properties and T
g
 of the polymer did not 




 treatments. However, 
GPC showed a decrease in the Mw and Mn after 10 minutes 
of O
2
 modification, suggesting a time less than 10 minutes 
should be used to prevent the degradation of nanocomposite 
materials when using this treatment gas. The surface elastic 
























Figure 6 Tissue integration of the plasma-modified scaffolds in a subcutaneous implantation mouse model for 6 and 12 weeks.
Notes: (A) Tissue ingrowth was found to be increased after 6 and 12 weeks on Ar-modified scaffolds compared with N2- and O2-modified scaffolds and unmodified (Con) 
scaffolds using h&e staining. Tissue integration for O2- and N2-modified scaffolds demonstrated similar levels. Scale bar: 300 µm. (B) Quantification revealed Ar with the 
highest tissue ingrowth compared with other scaffolds. All scaffolds were treated with 5 minutes of respective plasma surface modification. *P,0.05, **P,0.01.
Abbreviations: ar, argon; con, untreated; N2, nitrogen; O2, oxygen.





modulus increased after increasing exposure of O
2
 treatment, 
which could be due to oxidative degradation and repolymer-
ization of polymer forming harder interfaces.44 Tiganis et al 
demonstrated that an increase in the Young’s modulus at the 
specimen surface of acrylonitrile butadiene styrene using 
micro-indentation measurements indicated degradation of 
the polymer causing the polymer to become brittle and fail.44 
However, further analysis and reports into polymer degrada-
tion are needed to account for this observation.
To find optimum cell culture conditions, HDF cells were 
cultured on PSM-treated polymers for various treatment 
times. It was interesting to note that, after 5 minutes of expo-
sure, all PSM treatments enhanced the adhesion (Figure 2A) 
and growth (Figure 3A and B) of HDFs on the scaffolds. 
Cells do not directly interact with synthetic materials but 
attach to the absorbed layer of proteins on the material sur-
face. Protein adsorption was greater on the PSM surface, cor-
relating with enhanced cell adhesion on modified compared 
with unmodified scaffolds (Figure 4A). It is hypothesized that 
although there was low protein adsorption on unmodified 
scaffolds, the conformation was correct allowing for spread-
ing of the fibroblasts similar to plasma-modified scaffolds, 
but the lower protein adsorption resulted into low levels of 





, there was more protein available causing 
higher cell attachment and cell spreading (Figure 4A). 
Among three gases for treatment, Ar showed the highest 
protein adsorption and thus cell attachment. To understand 
&RQ $U 1 2












































Figure 7 Angiogenesis of the plasma-modified scaffolds after five minutes of treatment.
Notes: (A) Angiogenesis assessment after 12 weeks in a mouse model. Vessel ingrowth was identified using CD31 marker, where the number of capillaries was identified 
(red arrows). scale bar: 250 µm. (B) Quantification showed a significantly higher capillary count on Ar-modified scaffolds compared with N2 and O2-modified scaffolds. 
(C) Analysis of the secretion of VEGF and bFGF by human dermal fibroblasts. Left: VEGF secretion measured by ELISA demonstrates increased protein secretion on the 
Ar-modified scaffolds at 7, 10 and 14 days by the HDFs compared with N2 and O2-modified scaffolds and unmodified scaffolds (Con). Right: The mRNA expression of VEGF 
and bFGF at 14 days was increased on the Ar-modified scaffolds compared with N2- and O2-modified scaffolds. Fold change represents the differences in the expression of 
the housekeeping gene GAPDH between cells grown on unmodified scaffolds (Con) and modified scaffolds. *P,0.05, **P,0.01.
Abbreviations: Ar, argon; bFGF, basic fibroblast growth factor; Con, untreated; N2, nitrogen; O2, oxygen; VegF, vascular endothelial growth factor.
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the reason behind this, further analysis of the cell–protein 
interaction was undertaken.
Cells recognize adsorbed proteins via integrins, which 
are linked between the ECM and the actin cytoskeleton.45,46 
Integrins form focal adhesion complexes when cells are 
adhered. Such complexes contain structural proteins includ-
ing vinculin, α-actin and talin, and signaling molecules such 
as paxillin and FAK.46,47 We observed an increase in the 
expression of vinculin, paxillin, talin and FAK by the HDFs 
on Ar-modified scaffolds. This may have contributed to the 
increase in cell adhesion and long-term growth observed on 
Ar-modified scaffolds compared with other PSM scaffolds.
Interestingly, this study also found that adhesion of the 
HDFs to the plasma-modified scaffolds occurred through dif-
ferent integrins. The integrin-blocking experiment showed a 









-integrin antibody was used. This observation confirms 
the role of fibronectin on these surfaces, which is known to 




 integrin receptor.46 
But the decrease in cell attachment was only observed on 




-integrin antibody was 
used, suggesting a predominate role of vitronectin in cellular 
attachment on these scaffolds.47 However, as the percentage 





integrin antibody on Ar-treated scaffolds, role of other cell 
surface receptors cannot be overlooked.
The data presented in this study show that the PSM scaf-
folds provide an optimum interface in terms of chemistry 
and topography after 5 minutes of treatment. The changes 
in the interfacial surface of polymer facilitated an optimum 
concentration and conformation of selective adhesion pro-
teins, which resulted in enhanced cell attachment, growth and 
cellular function. It is possible that these interfacial changes 
induced by Ar allowed the highest number of proteins to 
be adsorbed in their optimal conformation due to moderate 
changes in surface hydrophilicity, roughness and surface 
chemistry. These surface changes resulted in higher cell 





 treatments. Figure S8 schematically explains this 
concept in more detail.
The observed short-term cell behavior was maintained 
in the long-term culture. The long-term cell survival and 
growth of HDF cells also led to the upregulation of several 
ECM-related genes including collagen type I, fibronectin, 
elastin and laminin (Figure 5). HDFs on Ar-treated scaffolds 
continued to express the highest level of ECM-related genes 
and also deposit corresponding ECM proteins (Figure S6). 
This confirmed that PSM enhances cellular function not 
only in the short term but also in long-term in vitro culture. 
Previous studies using PSM also showed an increase in the 
ECM production for other anchorage-dependent cells such 
as osteoblasts and chondrocytes.48,49
To ascertain the observed cellular behavior is not an 
effect of in vitro culture, further in vivo studies were con-
ducted using mice model. Histological analysis of explanted 
scaffolds after 6 and 12 weeks showed a significantly higher 
level of tissue integration on PSM scaffolds compared with 
untreated scaffolds. However, it was highest on Ar-modified 




-treated scaffolds. Fibrous 
capsule formation around synthetic implants during in vivo 
studies is a common phenomenon. Examining the extent of 
fibrous capsule thickness can serve as good indicator of tissue 
material reaction. This study showed that the thickness of 
fibrous capsule formation on PSM scaffolds is significantly 
reduced compared with untreated scaffolds (Figure S7), sug-
gesting that PSM not only facilitates tissue integration but 
also minimizes the inflammatory reactions.
The development of new blood vessels after clinical 
implantation of a material for restoration of facial defects 
is a limiting factor in all three-dimensional bioengineered 
constructs. Many growth factors are responsible for angio-
genesis. Ring et al illustrated that dermal substitutes and 
allogenic bone implants enhanced their vascularization after 
Ar/hydrogen and Ar/O
2
 plasma treatment, respectively, using 
a dorsal skinfold chamber assay.50,51 In the current study, all 
plasma treatments led to increase in angiogenesis compared 
with untreated scaffolds. Ar treatment revealed the highest 
vessel formation as shown by CD31 staining (Figure 7A 
and B). During in vitro culture, HDFs secreted the highest 
amounts of VEGF (Figure 7C), which might have supported 
a greater influx and proliferation of endothelial cells and 
allowing for greater vessel formation in vivo.
In summary, to the best of our knowledge, this study for 
the first time reports a detailed investigation into the effect 
of various gases used for PSM on polymer surfaces and 
their effect on the short- and long-term tissue integration 
and angiogenesis. PSM significantly affected the surface 
chemistry of the polyurethane polymer, without affecting 
its bulk properties. Optimal PSM time for the polyurethane 
polymer was found to be 5 minutes based on both in vitro 





However, Ar modification was optimal for the polyurethane 
scaffolds in this study for the enhancement of cellular integra-
tion and angiogenesis. This is due to the unique combination 
of surface chemistry and topographical modification this 
treatment gas imparts.






Ar PSM is a simple, fast and very effective method of sur-
face modification that can improve tissue integration and 
angiogenesis of polyurethane implants. Future work will 
investigate the effect of Ar surface modification on further 
clinically approved biomedical materials to assess its effec-
tiveness at the clinical bedside.
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Figure S1 SEM images of the surface of the scaffolds modified with Ar, N2 and O2 using plasma surface modification for various length of time.
Note: scale bar: 2 µm.












































Figure S2 GPC after 5 and 10 minutes of plasma surface modification using Ar, N2 and O2 treatment.
Notes: (A) Effect of plasma modification on Mw. (B) Effect of plasma modification on Mn. (C) Effect of plasma modification on PDI. No significant changes were found 
after 5 or 10 minutes of ar or N2 treatment. Ten minutes of O2 treatment caused a significant decrease in the Mw and Mn compared with unmodified scaffolds (P,0.05). 
**P,0.01.
Abbreviations: ar, argon; con, untreated; gPc, gel permeation chromatography; Mn, molecular number; Mw, molecular weight; N2, nitrogen; O2, oxygen; PDI, polydispersity 
index.
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Figure S3 Mechanical properties of the scaffolds after plasma surface modification.
Note: Plasma surface modification showed no change in the tensile Young’s elastic modulus for all exposure times (up to 10 minutes).
Abbreviations: ar, argon; con, untreated; N2, nitrogen; O2, oxygen.
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Figure S4 DSC after 5 and 10 minutes of plasma surface modification using Ar, N2 and O2 treatment.
Note: This study showed no changes in the Tg after 5 and 10 minutes of plasma surface modification using Ar, N2 or O2 compared to untreated scaffolds (con).
Abbreviations: ar, argon; Dsc, differential scanning calorimetry; N2, nitrogen; O2, oxygen; Tg, glass transition temperature.

















































Figure S5 Functional presentation of cell-binding domains of adsorbed fibronectin and vitronectin after plasma surface modification. Total fibronectin (A) and (B) vitronectin 
protein adsorption onto the scaffolds after 1 hour with 5 minutes of plasma surface modification exposure was analyzed using mAB.
Notes: after 5 minutes of N2 or O2 modification, greater amount of fibronectin was absorbed onto the scaffolds compared with Ar-modified and unmodified scaffolds (Con). 
Vitronectin adsorption was the greatest after 5 minutes of Ar modification compared with all other scaffolds.












Figure S6 ECM formation by the human dermal fibroblasts after plasma surface modification. Immunocytochemistry confirmed the expression of the ECM markers after 
14 days on the plasma-modified and untreated scaffolds (green: collagen type I, elastin, fibronectin; blue: DAPI).
Note: scale bar: 20 µm.
Abbreviations: ar, argon; con, untreated; ecM, extracellular matrix; N2, nitrogen; Neg con, negative control where primary antibody was omitted; O2, oxygen; TcP, 
tissue culture plate.
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Figure S7 Fibrous capsule formation of the scaffolds treated with plasma surface modification after 12 weeks of subcutaneous implantation.
Notes: (A) Histological sections representing thickness of fibrous capsule at the interface of implant and subcutaneous tissue. Scale bar: 200 µm. (B) Quantification of fibrous 
capsule thickness shows significantly higher fibrous capsule thickness on the unmodified scaffolds compared with plasma-treated scaffold (*P,0.05).























Figure S8 Schematic representation of the mechanism by which cells interact with unmodified and plasma surface-modified scaffolds using Ar, N2 and O2 plasma 
treatments.
Notes: Control scaffolds show lower protein adsorption and cell attachment, Ar-modified scaffolds show moderate roughness, with higher VN adsorption from serum 
protein, N2 plasma-modified scaffolds show higher FN adsorption compared with O2 plasma-modified scaffolds, which exhibit the highest surface roughness. Image not to 
the scale.
Abbreviations: Ar, argon; FN, fibronectin; N2, nitrogen; O2, oxygen; VN, vitronectin.
